ArticleOncology research2024

Bendamustine and rituximab as frontline therapy in extranodal marginal zone lymphoma: a single-institution experience.

Constantine N Logothetis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.